The Expanding Role of Hospitals and Clinics in the Blood Plasma Derivatives Market
The global demand for blood plasma derivatives is soaring, driven by a growing patient population with chronic and rare diseases. This creates a constant and urgent need for plasma donations. Unlike whole blood, which is often used in a single transfusion, a single dose of a plasma-derived medicine, such as IVIG for an immune deficiency patient, requires plasma from hundreds or even thousands of donors. This makes plasma a precious and highly valued resource. The increasing number of plasma collection centers around the world is helping to meet this demand, but the need for new and regular donors remains constant. Donating plasma is a direct way to save and improve the lives of millions of people who depend on these life-saving therapies. This critical need for donation is a major factor shaping the dynamics of the Blood Plasma Derivatives Market.